POPULARITY
Categories
325 episodes with pharmd
196 episodes with pharmd
166 episodes with pharmd
153 episodes with pharmd
210 episodes with pharmd
173 episodes with pharmd
98 episodes with pharmd
151 episodes with pharmd
134 episodes with pharmd
105 episodes with pharmd
116 episodes with pharmd
112 episodes with pharmd
96 episodes with pharmd
62 episodes with pharmd
39 episodes with pharmd
59 episodes with pharmd
55 episodes with pharmd
51 episodes with pharmd
83 episodes with pharmd
45 episodes with pharmd
114 episodes with pharmd
93 episodes with pharmd
39 episodes with pharmd
33 episodes with pharmd
40 episodes with pharmd
41 episodes with pharmd
28 episodes with pharmd
44 episodes with pharmd
75 episodes with pharmd
33 episodes with pharmd
26 episodes with pharmd
47 episodes with pharmd
21 episodes with pharmd
31 episodes with pharmd
21 episodes with pharmd
28 episodes with pharmd
15 episodes with pharmd
25 episodes with pharmd
24 episodes with pharmd
23 episodes with pharmd
53 episodes with pharmd
19 episodes with pharmd
24 episodes with pharmd
12 episodes with pharmd
20 episodes with pharmd
34 episodes with pharmd
16 episodes with pharmd
18 episodes with pharmd
40 episodes with pharmd
27 episodes with pharmd
24 episodes with pharmd
53 episodes with pharmd
11 episodes with pharmd
16 episodes with pharmd
19 episodes with pharmd
20 episodes with pharmd
17 episodes with pharmd
16 episodes with pharmd
32 episodes with pharmd
17 episodes with pharmd
40 episodes with pharmd
22 episodes with pharmd
20 episodes with pharmd
18 episodes with pharmd
15 episodes with pharmd
19 episodes with pharmd
8 episodes with pharmd
14 episodes with pharmd
14 episodes with pharmd
14 episodes with pharmd
28 episodes with pharmd
12 episodes with pharmd
5 episodes with pharmd
10 episodes with pharmd
12 episodes with pharmd
14 episodes with pharmd
9 episodes with pharmd
18 episodes with pharmd
18 episodes with pharmd
19 episodes with pharmd
14 episodes with pharmd
4 episodes with pharmd
9 episodes with pharmd
20 episodes with pharmd
16 episodes with pharmd
19 episodes with pharmd
22 episodes with pharmd
8 episodes with pharmd
9 episodes with pharmd
18 episodes with pharmd
16 episodes with pharmd
10 episodes with pharmd
9 episodes with pharmd
5 episodes with pharmd
10 episodes with pharmd
12 episodes with pharmd
8 episodes with pharmd
12 episodes with pharmd
3 episodes with pharmd
6 episodes with pharmd
6 episodes with pharmd
17 episodes with pharmd
10 episodes with pharmd
6 episodes with pharmd
3 episodes with pharmd
13 episodes with pharmd
12 episodes with pharmd
6 episodes with pharmd
5 episodes with pharmd
3 episodes with pharmd
8 episodes with pharmd
15 episodes with pharmd
3 episodes with pharmd
98 episodes with pharmd
5 episodes with pharmd
15 episodes with pharmd
4 episodes with pharmd
3 episodes with pharmd
5 episodes with pharmd
8 episodes with pharmd
5 episodes with pharmd
4 episodes with pharmd
9 episodes with pharmd
9 episodes with pharmd
6 episodes with pharmd
8 episodes with pharmd
3 episodes with pharmd
7 episodes with pharmd
4 episodes with pharmd
5 episodes with pharmd
8 episodes with pharmd
4 episodes with pharmd
5 episodes with pharmd
7 episodes with pharmd
4 episodes with pharmd
6 episodes with pharmd
3 episodes with pharmd
4 episodes with pharmd
4 episodes with pharmd
9 episodes with pharmd
10 episodes with pharmd
5 episodes with pharmd
4 episodes with pharmd
10 episodes with pharmd
8 episodes with pharmd
5 episodes with pharmd
11 episodes with pharmd
4 episodes with pharmd
3 episodes with pharmd
4 episodes with pharmd
7 episodes with pharmd
6 episodes with pharmd
9 episodes with pharmd
7 episodes with pharmd
7 episodes with pharmd
4 episodes with pharmd
6 episodes with pharmd
4 episodes with pharmd
4 episodes with pharmd
3 episodes with pharmd
5 episodes with pharmd
5 episodes with pharmd
5 episodes with pharmd
4 episodes with pharmd
7 episodes with pharmd
4 episodes with pharmd
65 episodes with pharmd
3 episodes with pharmd
2 episodes with pharmd
3 episodes with pharmd
6 episodes with pharmd
7 episodes with pharmd
3 episodes with pharmd
4 episodes with pharmd
7 episodes with pharmd
6 episodes with pharmd
2 episodes with pharmd
6 episodes with pharmd
3 episodes with pharmd
9 episodes with pharmd
Only roughly 50% of new GLP-1 prescriptions were getting approved for coverage in 2023. From a plan sponsor's seat, that looks like pharmacy trend spiking 9%, 12%, even 20% year over year. From a pharma manufacturer's seat, it's half their prescriptions not getting filled. Same market, opposite problems — and that's exactly the lens this episode flips on. In this episode, Stacey Richter speaks with Ophelia Johnson, who built new business channels for a pharmaceutical manufacturer that created the GLP-1 boom and has since launched a consulting practice at e-fi.works, about how cash pay models work from the inside — coupon platforms, telehealth channels, white label pharmacy models, and employer carve-outs — and where the new fees are hiding. WHAT YOU'LL LEARN ✅ How the Inflation Reduction Act, PBM legal scrutiny, drug shortages, and the compounding bypass converged with ~50% GLP-1 prior auth denial rates in 2023 to push pharma into building cash pay channels that cut the PBM out entirely ✅ How the savings coupon model works: manufacturer buys the patient down to a flat transparent cash price via platforms like GoodRx, pays a fixed per-script fee instead of a PBM rebate, and the coupon platform makes the pharmacy whole — transparent math, no black box ✅ How the telehealth channel and white label pharmacy models extend the distribution chain beyond retail — and why shipping costs, credit card fees, dispensing fees, and new supply chain partners create gross-to-net and revenue leakage risk for manufacturers not built for it ✅ Why "direct to employer" is a misnomer: PBM contracts prohibit pharma from selling directly to self-insured employers, so third-party transparent administrators have emerged — but plan sponsors need to run the math first, given ERISA complications and PBM contract leverage ✅ How PBMs are now charging fees for hub-like patient support services to manage the exact prior auth complexity they created — a Whack-a-Mole shift of profitability that everyone needs to map before signing anything ✅ Ophelia's three-part practical advice: map the full patient journey and all ecosystem player incentives before building any new model (pharma); treat affordability as a clinical risk factor (clinicians); demand auditable medication abandonment data rather than settling for rebate yield metrics (plan sponsors) WHY THIS MATTERS If collaboration is the next innovation, everyone has to understand the incentives of every player in the ecosystem — not just their own. The same 50% of unfilled GLP-1 prescriptions that looks like runaway pharmacy trend from a plan sponsor's seat looks, from a manufacturer's seat, like half their market going dark — and both sides are making moves that affect each other. Understanding those moves, where fees are being layered on, and when fair profit tips into what Stacey calls profiteering is what this episode maps. TUNE IN NEXT WEEK Next week is the 401-level companion to this one — Stacey goes solo on the PBM and GPO contracting mechanics behind why cash pay became a thing, and why cheaper or better drugs can inexplicably end up off formulary or buried under prior auth. === LINKS ===
What happens when learners teach learners? Layered learning is a teaching model that brings pharmacy students, residents, and preceptors together in a collaborative learning environment. Our host Carolyn Liptak is joined by Dr. Sarah Eggers Russell, PharmD, BCACP, CPP of UNC Health REX and Dr. Kimberly James, PharmD of UF Health to discuss how layered learning works in pharmacy residency programs and why it continues to gain traction across healthcare settings. They share perspectives from their own programs and discuss what it takes to create meaningful learning experiences for learners at every stage of training. Guest Speakers: Dr. Sarah Eggers Russell, PharmD, BCACP, CPP UNC Health REX Dr. Kimberly James, PharmD UF Health Host: Carolyn Liptak, MBA, BS Pharm Pharmacy Executive Director, Regulatory Compliance Vizient Center for Pharmacy Practice Excellence Show Notes: 00:05 - What Is Layered Learning? Definition of layered learning and its role in pharmacy education How teaching, mentorship, and patient care occur simultaneously Benefits for learners, preceptors, and patients 01:08 - Residency Program Overviews UNC Health Rex ambulatory care residency program UF Health pediatric pharmacy residency program Opportunities for students, residents, and advanced learners across diverse practice settings 02:22 - How Layered Learning Works in Practice Senior learners mentoring junior learners under pharmacist supervision Developing teaching skills and professional behaviors Expanding direct patient care opportunities while supporting preceptor workloads 03:33 - Defining Roles and Responsibilities Setting expectations before the rotation begins Assessing learner readiness for teaching responsibilities Creating structured orientation processes for all learners Providing feedback and evaluation opportunities for resident preceptors 05:55 - Adapting to Different Learning Styles Tailoring rotations to individual learner needs Gradually increasing clinical responsibilities Using regular feedback sessions and midpoint evaluations Building confidence through progressive independence 08:20 - Building Successful Layered Learning Experiences Differences between primary and co precepting models Leveraging learners to expand patient access and clinical services Using shared precepting across diverse practice environments Creating opportunities for leadership and teaching development 10:42 - Keeping Learners Engaged in Ambulatory Care Managing clinic schedules and patient encounters Evidence based patient case presentations Topic discussions, drug information requests, and interdisciplinary shadowing opportunities Exposure to diagnostic testing and specialty practice areas 12:13 - Structuring Layered Learning in the Inpatient Setting Working across multiple specialty consult services Presenting to interdisciplinary healthcare teams Shadowing opportunities with nursing and other disciplines Using projects to improve patient care and learner engagement 13:39 - Advice for First Time Preceptors Maintaining flexibility and adaptability Meeting learners where they are in their development Keeping communication open through regular check ins Encouraging learners to embrace new challenges and teaching opportunities 14:51 - The Lasting Impact of Layered Learning Benefits for junior learners, advanced learners, and preceptors Strengthening interdisciplinary collaboration Increasing awareness of pharmacy residency programs Bringing fresh perspectives and new ideas into clinical practice 16:34 - Resources and What's Next ASHP Guide for Best Practices of Layered Learning Upcoming Vizient Layered Learning Toolkit currently in development Links and Resources: Residency-Guide_Best-Practices-for-Resident-Engagement-in-LLM_Final.ashx Subscribe Today! Apple Podcasts Spotify YouTube RSS Feed
Send us Fan MailSchedule an Rx AssessmentWelcome to the inaugural Bottom Line Catch Up and Hawaiian Shirt Friday at Sykes & Company, and the team is back together including Bonnie, who survived a grizzly bear encounter in Yellowstone for a wide-ranging post-tax season catch-up.In this episode, we break down the hottest topics right now in pharmacy including:Transition conversationsMulti-store expansion opportunitiesWhy peptides may be the biggest thing to ever hit compounding pharmacyAnd more!Stay connected with us: FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP TwitterBonnie Bond – CPA LinkedInBonnie Bond – CPA TwitterMore resources on this topic:Podcast – Driving Independent Pharmacy Profitability in 2026 with Nicolette Mathey, PharmD, CEO of Atrium24Podcast – 2026 Quarter 2 Pharmacy UpdatePodcast – Building a Super Culture in Your Pharmacy
On this episode of This Week in Pharmacy, we bring together three powerful voices shaping the future of pharmacy, independent practice, functional medicine, and healthcare transformation. First, we welcome Kris Rhea, MBA, Contributing Editor with Dispense Times, a digital publication dedicated to supporting independent community pharmacy owners across the United States. Kris brings a business-focused perspective on pharmacy operations, growth strategy, workflow efficiency, data-driven decision-making, and market positioning. His work with Dispense Times helps independent pharmacists navigate today's rapidly changing healthcare landscape, including PBM pressures, evolving patient expectations, regulatory challenges, and the need for sustainable business models that keep local pharmacies strong. We also speak with James Maskell, founder of Evolution of Medicine, an organization built to inspire, equip, and unite functional and integrative medicine practitioners. Evolution of Medicine provides education, practice-building resources, and community for clinicians who are working to build thriving practices rooted in whole-person care. James brings a national perspective on the movement toward functional medicine, community-based care, prevention, and new models that empower practitioners to better serve patients beyond the limitations of conventional healthcare. Our third guest is Marina Buksov, PharmD, a pharmacist, herbalist, educator, podcast host, and holistic health consultant. After earning her PharmD from St. John's University and graduating Summa Cum Laude in 2013, Marina entered pharmacy eager to serve patients, but quickly recognized that traditional allopathic pharmacy did not fully align with her deeper calling to help people thrive through prevention, root-cause care, plant medicine, and sustainable wellness strategies. Her experience behind the pharmacy counter and as a patient herself inspired her to pursue health coaching, nutrition, functional medicine, and clinical herbalism. Today, Marina helps pharmacists and healthcare professionals explore natural-minded career paths and build meaningful work that bridges pharmacology, herbal therapeutics, and holistic care. Together, this episode explores where pharmacy is headed: independent pharmacy survival, business model innovation, functional medicine, patient-centered care, pharmacist reinvention, and the growing demand for healthcare professionals who can connect science, prevention, and real-world practice. Listen to This Week in Pharmacy on the Pharmacy Podcast Network. Pharmacy's future is being built by those willing to challenge the current model, support independent practice, and expand the role of pharmacists as trusted healthcare providers.
On episode 109 of Astonishing Healthcare, host Justin Venneri explores pharmacogenomics (PGx) with a trio of experts: Caitlin Munro, PharmD (Clinical Partnerships Lead, Judi Health); Haleh Campbell, PharmD (Clinical Programs Administration Manager, Judi Health); and Houda Hachad, PharmD (Vice President of Clinical Operations, Aranscia). Together, they break down what PGx is, why now is the right moment for broader adoption, and how genetics can shape the way each of us processes and responds to medications.The conversation moves from the basics to the practical: where the evidence is strongest, which patients stand to benefit most, and what it takes to apply PGx in a way that's clinically responsible and genuinely useful for patients and providers. They also dig into findings from a study the Judi Health team recently presented at the Pharmacy Quality Alliance (PQA) annual meeting and explain why pharmacist support and clinical decision support, not just a lab report, make all the difference.Key TakeawaysPGx adds a piece to the puzzle; it's not a silver bullet. Pharmacogenomics looks at how inherited genetic differences affect the way a person processes or responds to medications. It narrows uncertainty and supports clinical judgment, but it doesn't replace it.Several forces are converging to make this the right moment. Testing costs have dropped, evidence-based guidelines from expert consortia are now widely adopted, and hundreds of FDA labels include pharmacogenomic information.The strongest use cases involve complexity and risk. Patients on multiple medications, those starting new therapies, and people who've had treatment failures or unexpected side effects often benefit most, especially across common drug classes like antidepressants, cardiovascular medications, and pain therapies.Human support drives engagement and trust. Rx Helix data showed that testing adoption was significantly higher among members who received clinician-led, pre-test telephone outreach.The future is proactive. With unified claims processing that combines pharmacy and medical data, leaders see a path toward PGx-enabled medication management, identifying patients before therapy begins to optimize treatment earlier in their journey.Related ContentHealth Benefits 101: The Importance of Clinical ProgramsAH073 - How Low Cost Alternative Programs Can & Should Work, with Jackie Lolos, PharmD, and Haleh Campbell, PharmDReplay – The Bridge to Better Healthcare: Uniting Medical and Pharmacy Services on One Platform to Achieve Value-Based CareAH060 - A New Approach to Colorectal Cancer (CRC) Screening, with GeneoscopyFor more information about this episode and its transcript, please visit Judi Health Insights.
Stephanie Lee, PharmD, and Isabel A. Mangaoang, PharmD, join CHEST® Critical Care Podcast Moderator Gretchen Sacha, PharmD, BCCCP, FCCM, to discuss their research into the sedation gap that can occur in patients who are critically ill and undergoing bedside procedural paralysis. This episode is part of a new series exploring articles published in our open access journal CHEST Critical Care. BRIDGE THE GAP DOI: 10.1016/j.chstcc.2026.100237 MIND THE GAP DOI: 10.1016/j.chstcc.2024.100089 Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers' opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.
Send us Fan MailSchedule an Rx AssessmentWhat does it mean to truly build a pharmacy people are excited to walk into as employees and patients?In this episode of the Bottom Line Pharmacy Podcast Dr. Emlah Tubuo, PharmD, MS, Host of The Intentional Living Pharmacist and Owner of Powell Pharmacy sits down with us to discuss intentional living. We cover: The four pillars of intentional living How to apply that framework inside your pharmacy What it really takes to build a thriving independent pharmacyAnd more!Stay connected with Emlah, The Integrative Pharmacist, and The Intentional Living Pharmacist Podcast: Emlah's LinkedInEmlah's InstagramPowell Pharmacy FacebookIntentional Living PodcastThe Integrative Pharmacist WebsiteStay connected with us: FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP TwitterBonnie Bond – CPA LinkedInBonnie Bond – CPA Twitter More resources on this topic: Podcast – Driving Independent Pharmacy Profitability in 2026 with Nicolette Mathey, PharmD, CEO of Atrium24Podcast – 2026 Quarter 2 Pharmacy UpdatePodcast – Building a Super Culture in Your Pharmacy
Julia Vu, PharmD, joins Over the Counter to discuss the NCPDP's role in advancing the pharmacy profession through its standards as well as staying up to date on various developments that affect the industry as a whole.
Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives!In this episode, shot live at the American Diabetes Association (ADA) Scientific Sessions 2026 in New Orleans, Louisiana, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss the latest major trial results like CONNECT, TRIUMPH, and TRANSCEND.To begin the episode, Isaacs and Bellini, discuss major highlights from ADA Scientific Sessions, focusing first on the landmark CONNECT trial evaluating continuous glucose monitoring (CGM) in people with type 2 diabetes who are not treated with insulin. They reflect on the evolution of CGM technology, from its early use primarily in type 1 diabetes to its expanding role in type 2 diabetes management, and explain why this trial represents an important step forward for patients who have historically had limited access to CGM.The hosts review the randomized controlled trial findings, emphasizing the significant improvements in glycemic outcomes, including a 1.6% reduction in A1c from baseline and an approximately 0.9% greater reduction compared with standard care. They also highlight the increase in time in range, with participants using CGM achieving roughly five additional hours per day in target glucose range. The magnitude of these findings is discussed as a practice-changing development, with the potential to influence future clinical guidelines and strengthen recommendations for CGM use among individuals with type 2 diabetes who are not using insulin.The discussion also explores the broader implications of the CONNECT trial for healthcare access and insurance coverage. The hosts note that randomized controlled trial evidence has historically played a key role in shaping standards of care and payer decisions, and they suggest that these results may help support wider adoption of CGM by demonstrating meaningful improvements in glucose control and patient outcomes.The conversation then shifts to emerging pharmacologic advances, with a focus on retatrutide, a novel triple agonist targeting GLP-1, GIP, and glucagon pathways. The hosts discuss new data showing substantial metabolic benefits in people with type 2 diabetes, including up to 17% weight reduction and nearly 2% A1c lowering. They highlight how these findings represent a major advancement in diabetes and obesity treatment, particularly as clinicians continue to see increasingly powerful effects from next-generation incretin-based therapies.Isaacs and Bellini explore how these therapies may reshape treatment strategies by allowing clinicians to tailor medication choices based on individual patient needs and goals. They discuss the importance of considering both glucose lowering and weight reduction effects, recognizing that some patients may benefit from significant weight loss while others may require a more balanced approach focused primarily on glycemic improvement.The hosts also address important unanswered questions surrounding the use of highly effective weight-loss medications, including appropriate treatment targets, the limitations of BMI as a measure, and the importance of preserving muscle mass and overall function. They emphasize the need to consider body composition, physical activity, resistance training, and patient characteristics—particularly in older adults or those at risk for frailty—when developing long-term treatment plans.The episode concludes with a reflection on the rapidly evolving landscape of diabetes care. The hosts highlight how advances in CGM technology and novel metabolic therapies are creating new opportunities to improve outcomes, personalize treatment approaches, and redefine the future management of people living with diabetes.Editors' Note: Isaacs reports disclosures with Dexcom, Abbott, Lilly, Novo Nordisk, Medtronic, Insulet, and others. Bellini reports disclosures with Abbott Diabetes Care, MannKind, Povention Bio, and others.
Why Prescriptions Weren't Enough: A Clinical Pharmacist's Wake-Up Call! Dr. Curt Dearing with Nutrition World: Curt Dearing-Clinical Pharmacist, Pharm.D., Integrative Pharmacy Specialist (our conversation does not replace your advice from your doctor - we are not giving medical advice or claiming to cure illness - we are sharing personal stories - please always consult your doctor before you start any supplements or stop taking any medications! This is for entertainment purposes) ===== THANK YOU TO OUR SPONSORS: (Welcome to our NEW sponsor) Signal Investigations: https://www.signalpi.com/ Nutrition World: https://nutritionw.com/ Vascular Institute of Chattanooga: https://www.vascularinstituteofchattanooga.com/ The Barn Nursery: https://www.barnnursery.com/ Optimize U Chattanooga: https://optimizeunow.com/chattanooga/ Guardian Investment Advisors: https://giaplantoday.com/ Alchemy Medspa and Wellness Center: http://www.alchemychattanooga.com/ Our House Studio: https://ourhousestudiosinc.com/ Team Montieth Real Estate - Lori Montieth: https://www.findchattanoogarealestate.com/ Ballinger and Associates - Risk Management: https://ballingerandassociates.com/ AirSpace Acoustics: https://www.airspaceacoustics.com/ BWELL4EVER: Labs and IV Therapies: https://www.bwell4ever.org/ ALL THINGS JEFF STYLES: www.thejeffstyles.com PART OF THE NOOGA PODCAST NETWORK: www.noogapodcasts.com Please consider leaving us a review on Apple and giving us a share to your friends! This podcast is powered by ZenCast.fm
With the launch of a new journal, the American Diabetes Association (ADA) is also launching a brand new podcast: The Points of CARE, the official podcast of Diabetes, Obesity, and CardioMetabolic CARE. Join hosts Richard Beaser, MD and Jane Reusch, MD, as they highlight key research findings, clinical implications, and emerging themes across diabetes, obesity, and cardiometabolic health through interviews with journal authors and subject-matter experts. 4:05 Our hosts speak with Anna Kahkoska, MD, PhD, Joan Heckler Gillings Assistant Professor in the Department of Nutrition and adjunct assistant professor of medicine in the Division of Endocrinology and Metabolism at the University of North Carolina at Chapel Hill, as well as Joshua Niznik, PharmD, PhD, assistant professor in the Division of Geriatric Medicine within the UNC School of Medicine. Their article, "Qualitative Analysis of Patient Portal Messages From Older Adults With Type 2 Diabetes," is available at doi.org/10.2337/doc25-0079. 14:10 Our hosts introduce Esben Thyssen Vestergaard, PhD, clinical associate professor in the Department of Clinical Medicine and Department of Pediatrics Aarhus University in Aarhus, Denmark. His article, "Clinic for Athletes With Type 1 Diabetes: Evaluation of a Structured Clinical Care Model for Physically Active Individuals," is available for free at doi.org/10.2337/doc25-0064. 21:40 Finally, Richard and Jane highlight some of their favorite articles from the May-June issue. Rezaeiahari, et al. Rural–Urban Differences in Use of Diabetes Self-Management Education and Support in Arkansas, 2015–2019 doi.org/10.2337/doc25-0065 Liu, et al. Trends in Nutrient Intake Among U.S. Adults by Diabetes Status: National Health and Nutrition Examination Survey 2011–2020 doi.org/10.2337/doc25-0076 Yanez Bello, et al. Barriers to the Adoption of Diabetes Technologies and the Implementation of Connected Insulin Pens in a Largely Minority Population With Type 1 Diabetes doi.org/10.2337/doc25-0072 Shehab, et al. Barriers to Effective Type 2 Diabetes Care in a Conflict-Affected Region of Syria: A Qualitative Study of Health Care Provider Perspectives doi.org/10.2337/doc26-0021 ElSayed, et al. Enhancing Physician Clinical Competency: A Cluster Randomized Trial of a Multimodal Online Educational Program in a Multinational Diabetes Workforce doi.org/10.2337/doci25-0007 Olesen, et al. A Danish Nationwide Cohort of Foot Health in Individuals With Diabetes From the Danish Foot Status Database doi.org/10.2337/doc26-0002 To learn more about Diabetes, Obesity, and CardioMetabolic CARE please visit diabetesjournals.org/docm-care. Thank you for listening, and don't forget to subscribe.
The Power of Functional Medicine: Finding the Root Cause of Chronic Health Problems In this episode of Stay Healthy Knoxville, Dr. John-Mark Chesney sits down with Emily Turner, PA-C, and Randy Martin, PharmD, of Omni Functional Medicine to discuss a different approach to healthcare—one focused on identifying and addressing the root causes of chronic symptoms rather than simply managing them. Together, they explore what functional medicine is, why so many people continue to struggle despite being told their labs are normal, and how factors such as hormones, gut health, stress, metabolism, and inflammation can impact overall health and well-being. Whether you're dealing with fatigue, weight gain, digestive issues, autoimmune disease, chronic pain, or simply aren't feeling your best, this conversation offers valuable insight into how a more personalized approach to healthcare may help uncover missing pieces of the puzzle. In This Episode, You'll Learn: ✅ What functional medicine is and how it differs from traditional healthcare ✅ Why patients can still feel unwell despite "normal" lab results ✅ The importance of looking for root causes instead of just treating symptoms ✅ How hormones, gut health, stress, and metabolism influence overall health ✅ Practical steps you can take to improve your health and energy About Our Guests Emily Turner, PA-C Bachelor's Degree in Dietetics – University of Kentucky Master's in Physician Assistant Studies – Sullivan University Advanced training through The Institute of Functional Medicine Advanced training through The American Academy of Anti-Aging Medicine Randy Martin, PharmD Doctor of Pharmacy – University of Tennessee Co-founder of Omni Functional Medicine Connect with Omni Functional Medicine Instagram: @omnifunctionalmedicine Website: omnifunctionalmedicine.com Enjoying the Podcast? Be sure to subscribe, leave a review, and share this episode with someone who may be searching for answers to ongoing health concerns. Stay healthy, Knoxville!
Diabetes Dialogue: Therapeutics, Technology, & Real-World Perspectives
Welcome back to Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives! In this special episode, shot live at the American Diabetes Association (ADA) Scientific Sessions 2026 in Ner Orleans, Louisiana, cohosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, are joined by Amit Gupta, MBBS, DNB, diabetologist, executive director of the Global Metabolic Health Alliance, and chair of the International Diabetes Federation (IDF) Education Committee, to discuss the state of diabetes care and treatment in India compared to the US.To begin the episode, Gupta introduces the mission of the IDF, highlighting its role as a worldwide federation of scientific societies and patient organizations focused on improving diabetes education, policy, advocacy, and access to care. The conversation explores how diabetes management differs across regions, emphasizing that while the underlying disease mechanisms and available therapies may be similar, access to medications, technologies, healthcare infrastructure, and education varies significantly between countries.Gupta discusses the impact of semaglutide becoming available as a generic therapy in India following patent expiration, describing how reduced costs have improved access to a medication previously limited by affordability barriers. The group considers how increased availability of GLP-1 receptor agonists may transform diabetes and obesity management, while also emphasizing that pharmacologic therapies alone cannot address the global metabolic health crisis. Gupta notes the importance of maintaining focus on long-term lifestyle changes, including nutrition, physical activity, and sustainable weight management, as essential components of comprehensive care.The discussion then shifts to diabetes education and the need for more individualized, patient-centered approaches. Gupta highlights that education must be adapted to regional and cultural contexts, explaining that the challenges faced by a person with diabetes in the United States, Africa, India, or other parts of the world may differ substantially, even though diabetes distress and the burden of daily decision-making are shared experiences. He emphasizes that access to technology, such as continuous glucose monitoring, does not eliminate the need for education and support.Isaacs, Bellini, and Gupta also address the growing challenge of misinformation online and the role of healthcare professionals in helping patients navigate unreliable sources of health information. Gupta explains that clinicians must approach misinformation constructively by providing evidence-based guidance rather than simply dismissing patients' beliefs, reinforcing the importance of translating scientific evidence into practical recommendations that patients can incorporate into their daily lives.The group further examines disparities in the availability of diabetes educators worldwide. Gupta notes that while some regions have established professional pathways for diabetes care and education specialists, many areas lack standardized training, recognition, or policy support to sustain these roles. He stresses that building effective diabetes education systems requires collaboration with policymakers to demonstrate the long-term benefits of structured education programs.The episode concludes with Gupta discussing his work developing a global consensus framework on lifestyle as the foundation of metabolic health. The conversation reinforces that advances in medications and technology must be paired with equitable access, effective education, and sustainable lifestyle interventions to reduce the global burden of diabetes and improve outcomes for people living with metabolic conditions.Editors' Note: Isaacs reports disclosures with Dexcom, Abbott, Lilly, Novo Nordisk, Medtronic, Insulet, and others. Bellini reports disclosures with Abbott Diabetes Care, MannKind, Povention Bio, and others. Gupta reports disclosures with Lilly, Abbott Diabetes, and the International Diabetes Federation.
Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) are serious conditions that often affect critically ill patients in ICUs. These infections carry a high risk of mortality and are frequently caused by multidrug-resistant bacteria like MRSA. On this episode of the ATS Breathe Easy podcast, Scott Micek, PharmD, University of Health Sciences and Pharmacy in St. Louis, explains to host Eddie Qian, MD, Vanderbilt University, why treating HABP/VABP needs to be tailored to the patient, how rapid diagnostics have pros and cons, and the importance of balancing aggressive early treatment with careful reassessment. This episode is sponsored by Innoviva Specialty Therapeutics.
On this episode of IPA's What, Why & How podcast, IPA's Vice President of Professional Affairs, Brian Wall, welcomes Anne Schlepphorst and Craig Ford to share insights from the May 5-6, 2026, Iowa Board of Pharmacy meeting, as well as advice for those interested in association or regulatory leadership roles. Anne Schlepphorst serves as the Executive Director of the Iowa Board of Pharmacy and Monitoring Bureau Chief. Prior to this role, Anne spent 6 years with the boards, most recently serving as Chief Investigator for the Iowa Boards of Pharmacy and Medicine. Craig Ford, PharmD, serves as MercyOne's Regional Director of Ambulatory Pharmacy, overseeing 25 pharmacies across the state, including retail, long-term care, and infusion pharmacies. He previously spent 17 years with Walgreens. Craig is an active IPA member, serving as an IPA Delegate and on IPA's Policy Committee on Professional Affairs. He was appointed by Governor Reynolds to serve his first term as a pharmacist member of the Iowa Board of Pharmacy, beginning May 1, 2026. More Information: May Meeting Agenda Sign Up for GovDelivery Updates Contact the Iowa Board of Pharmacy: ibp@dial.iowa.org 2025 Iowa Prescription Monitoring Program Annual Report Connect with us on LinkedIn: Anne Schlepphorst Craig Ford Brian Wall Iowa Pharmacy Association
Episode#336-Taped April 22, 2026 We talk about hormone health and hormone therapy. Research has shown that if we use hormone therapy safe and effectively within 10 years of menopause or before age 60 it can offer significant benefits including reduced bone fractures, improved cardiovascular health and reduced cognitive decline. But how does bioidentical hormone replacement therapy and personalized care play a significant role in hormone therapy? Joining us is Nayan Patel, PharmD, he is a clinical pharmacist, and founder of Central Drugs Compounding Pharmacy, a nationally respected facility specializing in bioidentical hormone therapy and personalized care. He will talk about hormone therapy, improving our energy, and our overall health and wellbeing from a pharmaceutical perspective. Dr. Patel will discuss his new book-“The Glutathione Revolution” and how this master antioxidant can help us fight disease, slow aging, and increase energy all the things that we need to have quality of life. Check out Dr. Patel's website Auro Wellness to find out about him and topical glutathione and his patent skincare products. Website: Auro Wellness Go buy Dr. Nayan Patel's Book The Glutatione Revolution It's All About Health & Fitness-Vicki Doe Fitness podcast Ranked on the Top 25 Midwest Fitness Podcasts to Listen to… with additional national recognition on the Top 100 US fitness podcast. Rate This Podcast Give us a 5-star review. We appreciate you! Take this quick audience survey. Thank you! FREE Metabolic Makeover Masterclass Webinar Replay! Learn how to reset your metabolism, boost energy, and support sustainable weight loss using simple, science-backed strategies. Enroll in the Vicki Doe Fitness Academy to get instant access to the replay and begin your healthy living journey today. Vicki Doe Fitness-STORE Discover the Vicki Doe Fitness-STORE—your destination for stylish apparel, fitness gear, and wellness essentials like yoga mats, water bottles, candles, and premium supplements. Shop now and elevate your health journey! Resources *Note: Some of the resources below may be affiliate links, meaning Vicki Doe Fitness receives a commission (at no extra cost to you) if you use the link to make a purchase. Thank you for your support! Herbs and spices are the keys to delicious, flavorful, and sophisticated meals! FREE DOWNLOAD- Herbs and Spices Cheatsheet Let's get ECO-friendly. Try ECOLunchbox.com ECOlunchbox specializes in stainless steel bento boxes, artisan fair trade lunch bags, napkins, snack sacks, and other eco-friendly lunchware. They are a certified green business. ECOlunchbox is a consumer products company started by an eco mom in the San Francisco Bay Area. ECOLunchbox.com Go to our Resources page- For the most recommended tools, you need to succeed on your healthy living journey!! Listen and share our podcast show- “It's All About Health & Fitness-” Vicki Doe Fitness Subscribe to Apple Podcast Subscribe on Stitcher Or on any of the platforms that you listen to your podcast! Watch & Subscribe on YouTube! Catch our latest health & wellness videos on YouTube at Vicki Haywood Doe – Vicki Doe Fitness YouTube-Vicki Haywood Doe-Vicki Doe Fitness Join us to receive a health wellness message!
This is a very special and heartfelt episode focused on depression, hope, recovery, and healing.Join us for an inspiring conversation with Dr. Lisa Zielbauer, PharmD, also known as Dr. Z, owner of Root Cause Rx and the voice behind Instagram accounts @RootCauseRx and @theMINDfulFARMacist. A Doctor of Pharmacy and Functional Medicine Consultant, Dr. Z courageously shares her personal journey with depression and anxiety, which began in high school and eventually led to a severe depressive episode requiring hospitalization shortly after pharmacy school.In this deeply honest discussion, Lisa opens up about the challenges she faced, the turning points that helped her find hope, and how connecting with others through the National Alliance on Mental Illness (NAMI) became a powerful part of her recovery. She shares the lessons she learned along the way and how those experiences inspired her to help others uncover the root causes of mental health struggles through a holistic and functional medicine approach.Listeners will walk away with practical tools and strategies for navigating difficult moments of depression, building resilience, and finding support during life's darkest seasons. Lisa also offers valuable guidance for friends and family members who want to better understand depression and learn meaningful ways to support a loved one who may be struggling.Whether you have personally experienced depression, are supporting someone who has, or simply want to gain a deeper understanding of mental health, this episode is filled with compassion, wisdom, and actionable takeaways that can make a real difference.Tune in for an empowering conversation about recovery, reducing mental health stigma, and discovering that healing—and hope—are possible. ❤️
In the Season 10 finale of the PQI Podcast, host Ginger Blackmon is joined by NCODA Fellow Shawnny Eugene, PharmD, as co-host for a special conversation focused on pharmacy fellowships and professional development. Together, they welcome three former fellows who have taken unique career paths following their fellowship experiences: Cooper Bailey, PharmD, Rahil Dixit, PharmD, and Utoy Wong, PharmD. Together, they share their journeys from pharmacy school to fellowship training and beyond, offering practical advice for students, residents, and pharmacists exploring both traditional and nontraditional career pathways. The conversation examines what pharmacy fellowships are, how they differ from residency programs, and the many opportunities available across oncology, nonprofit organizations, advocacy, and the pharmaceutical industry. The guests discuss the skills they developed during their training and the importance of mentorship and professional growth. They also reflect on how their fellowship experiences helped shape their careers and prepared them for leadership opportunities within their respective fields. Whether you are a student considering your next step, a graduate exploring career options, or a pharmacist looking to expand your professional horizons, this episode provides valuable insights into the evolving landscape of pharmacy fellowships and the impact they can have on career development. Learn more about NCODA and available professional development opportunities at ncoda.org
Sustaining critical care delivery in today's healthcare environment requires more than resilience—it also calls for collective solutions to systemic challenges. In this episode of the Society of Critical Care Medicine (SCCM) Podcast, Past President Jose L. Pascual, MD, PhD, FRCS(C), FACS, FCCM, elaborates on the session presented during the 2026 Critical Care Congress, Critical Care Under Pressure: Sustaining the Workforce and Infrastructure Amid Rising Demands. Joined by host Marilyn Bulloch, PharmD, BCPS, FCCM, Dr. Pascual examines the complex forces reshaping critical care, from shrinking ICU capacity and hospital closures to persistent workforce shortages and shifting training pipelines. He highlights concerning trends such as reduced entry into certain critical care pathways, particularly anesthesiology. At the same time, he points to encouraging growth in other pathways, with increasing participation from clinicians in emergency medicine, neurology, and surgery. The conversation underscores disparities in access to care, particularly for rural and community hospitals. Dr. Pascual explores the tension between the regionalization of specialized care and the need to maintain equitable access across health systems, emphasizing the importance of thoughtful resource distribution and collaboration across institutions. Beyond workforce numbers, the evolution of leadership in critical care is also impactful, including the migration of experienced clinicians into administrative roles and the potential need for cyclical leadership models that maintain clinical engagement. Meeting these challenges requires innovation and cooperation. Dr. Pascual highlights advancements in education, particularly the expansion of simulation-based training, as critical tools for maintaining competency and improving team performance. Resources referenced in this episode: 2026 Congress Digital
Send us Fan MailSend us Fan MailSchedule an Rx AssessmentWhat's really going on with peptides, AI, and the future of independent pharmacy? Turns out, quite a lot.Dr. Nicolette Mathey, PharmD, Founder and CEO of Atrium24 and Dotti CRM, for her quarterly update on the independent pharmacy landscape.We talk about:Headwinds and tailwinds for Q2 of independent pharmacyUpcoming PCAC meeting and what it means for peptide compoundingThe dangerous peptide gray marketHow AI is eliminating inefficiencies and transforming pharmacy salesAnd more!Stay connected with Nicolette, Atrium24, and Dotti: Nicolette's LinkedInAtrium24 WebsiteAtrium24 FacebookAtrium24 LinkedInStay connected with us: FacebookTwitterLinkedInScotty Sykes – CPA, CFP LinkedInScotty Sykes – CPA, CFP TwitterBonnie Bond – CPA LinkedInBonnie Bond – CPA Twitter More resources on this topic: Podcast – Driving Independent Pharmacy Profitability in 2026 with Nicolette Mathey, PharmD, CEO of Atrium24Podcast – A Pharmacists Run for Congress with Dr. Didi Okpareke, PharmD, RPhPodcast – KPIs for the Rapid Growth Pharmacy with Jim Hrncir, R. Ph, Owner of Las Colinas Compounding Pharmacy
“However much we flatter ourselves about our individual rationality, a good story, no matter how analytically deficient, lingers in the mind, resonates emotionally, and persuades more than the most dispositive facts or data.”Inspired by the article "The impact of cult behavior on haematopoietic cell transplant practices: believers and non-believers" (https://www.nature.com/articles/s41409-021-01473-w), in this episode, Anthony and Bernie are joined by transplant experts Tate Feeney, PharmD, BCOP and Aaron "Papa heme" Goodman, MD, to discuss "cult-like thinking" in hematology and BMT. We discuss why this occurs, go through some provocative examples, and talk about how to identify bias or ”cult-like thinking” in our own practices!Grab your favorite drink and prepare to join the wolverheme cult!
Sandra Leal, PharmD, MPH, joins Over the Counter to discuss the pharmacist's role in team-based diabetes care and how an evolving health care landscape allows for a significant boost in pharmacy-delivered clinical services.
In this episode of Mind the Meds, Erica Marini, PharmD, highlights information from the European Stroke Organization Conference include encouraging data on asundexian(Bayer), a factor XIa inhibitor showing reduced recurrent ischemic stroke risk without increased bleeding, as well as positive results from three trials of tirofiban in acute ischemic stroke settings. On the multiple sclerosis (MS) front, Marini covers the FDA approval of ocrelizumab (Ocrevus; Genentech) for pediatric relapsing-remitting MS in children 10 and older, a new study supporting early use of high-efficacy agents in pediatric MS, and 2 Lancet publications on ocrelizumab — one examining higher weight-adjusted dosing (which did not improve disability progression) and one confirming benefit in a broader primary progressive MS population. She also briefly discusses PADOVA (NCT04777331), a phase 2b trial of prasinezumab in early Parkinson's disease, which failed to meet its primary end point.The bulk of the episode is a discussion with guest Millad Sobhanian, PharmD, BCPS, clinical pharmacy specialist in neurology at the University of Maryland, focused on Alzheimer disease. They cover dextromethorphan/bupropion (Auvelity; Axsome Therapeutics), newly approved in April 2026 for agitation associated with Alzheimer dementia. Sobhanian walks through key safety considerations—including additive NMDA antagonism if combined with memantine, cardiovascular risks from the bupropion component, and the ever-present black box warning on antipsychotics in dementia patients—while both note that the efficacy data, though statistically significant, shows modest clinical effect sizes compared to the threshold for meaningful within-patient change.The conversation then turns to lecanemab's subcutaneous initiation formulation (Leqembi Iqlik; Eisai, Biogen), whose FDA decision has been delayed to about August 2026 as regulators seek more data on bioavailability and ARIA monitoring in the at-home setting. Sobhanian shares his real-world perspective on anti-amyloid therapy, describing a patient population that is typically early-stage, high-functioning, and has a mean age of about 60 to 70 years, and emphasizing the pharmacist's role in expectation-setting around the modest but potentially cumulative slowing of cognitive decline. The episode closes with a thorough discussion of the April 2026 Cochrane review on amyloid-targeting monoclonal antibodies, which both Marini and Sobhanian find overly broad in its conclusions. They note limitations such as the inclusion of withdrawn agents like aducanumab (Aduhelm; Biogen), heterogeneous inclusion criteria across trials, and an 18-month study horizon that may be too short to capture the full benefit suggested by longer-term open-label extension data.Key Takeaways:1. New options for Alzheimer's agitation exist, but fit carefully into the treatment algorithm. Dextromethorphan/bupropion offers a novel NMDA-based mechanism for treating agitation in Alzheimer dementia, but its clinical effect size is modest, and it carries meaningful safety considerations—particularly around the bupropion component in elderly patients. Like all pharmacologic options in this space, it remains a later-line choice after nonpharmacologic interventions have been exhausted, and medication reconciliation is critical given its interaction potential with memantine and CYP2D6 inhibitors.2. Anti-amyloid therapies are imperfect but not ready to be written off. The April 2026 Cochrane review drew significant attention with its conclusion that anti-amyloid monoclonal antibodies produce only trivial cognitive benefits, but its findings are limited by the inclusion of older, withdrawn agents, heterogeneous trial populations, and an 18-month time horizon that may be too short to capture the full trajectory of benefit.3. The pharmacist's role in anti-amyloid therapy goes well beyond dispensing. As illustrated by Sobhanian's practice at the University of Maryland, clinical pharmacists embedded in neurology clinics play a critical role in patient selection, expectation-setting, ARIA counseling, and informed decision-making for patients considering anti-amyloid therapy—a complex, high-stakes treatment decision that these patients and their caregivers should never be navigating alone.
Payer & Provider Dynamics: Addressing Non-Medical Switching in Oncology for CLL/SLL On this episode guest host Ryan Haumschild, PharmD, MS, MBA, CPEL, Vice President of Pharmacy at Emory University and Emory Health Plan, Winship Cancer Institute, discusses the real-world impact of non-medical switching in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) with Timothy Mok, Manager of Clinical Utilization Intelligence at Kaiser Permanente and board-certified oncology pharmacist, focusing on the drivers behind switching, the risks of disrupting effective therapy, and how shared decision-making and dose modification can help maintain adherence and improve patient outcomes. Sponsored by Abbvie. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/
In this episode of The Armor Men's Health Show, host Donna Lee sits down with VMC Pharmacy's Pharmacist-in-Charge, Aaron Zamanian, PharmD, for an inside look at the impressive compounding pharmacy at Victory Medical Center in Austin, TX
GLP-1 receptor agonists are reshaping diabetes and obesity care, raising important questions about patient selection, side effect management, long-term outcomes, access, and the evolving role of diabetes care and education specialists (DCESs). In this episode of Diabetes Care Conversations, host Paola Acevedo, PharmD, CDCES, speaks with Diana Isaacs, PharmD, BC-ADM, CDCES, about what DCESs need to know about GLP-1 therapies, including their impact on treatment approaches, the importance of patient education, and emerging opportunities and challenges in care. Listen to more episodes of Diabetes Care Conversations at https://www.adces.org/practice/the-huddle-podcast Learn more about ADCES and the many benefits of membership at adces.org/join. The Diabetes Care Conversations Podcast is edited by JAG Podcast Productions: https://jagpodcastproductions.com/ Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.
Early detection of chronic kidney disease (CKD) means little if it does not lead to timely treatment, yet a significant gap persists between when CKD is found and when evidence-based therapies are started. That disconnect is the focus of the second episode of Beyond the Silo: Integrated Care Across the CRM Continuum, a podcast series from The American Journal of Managed Care®, in which Ralph Riello, PharmD, BCPS, leads a conversation with Nihar Desai, MD, MPH, on how to shift CKD care from a reactive, late-stage model to one that is proactive, pathway-driven, and equitable. The discussion builds on the first episode's focus on urine albumin-to-creatinine ratio underutilization, stipulating that screening has occurred and asking what must happen next. You can listen to the first episode here: https://www.ajmc.com/link/89943
In today's episode, we continue our Vaccine Voices series. Host John Beckner takes a closer look at addressing vaccinations in the long-term care setting with guests Jeanne Manzi, PharmD, BCGP, FASCP and Deborah Milito, PharmD, BCGP, FASCP. Manzi and Milito share insights from their research in a recent white paper entitled: Immunization Insights: Bridging Gaps, Boosting Protection, and Building Trust. Thank you to Pfizer for sponsoring this episode. Read the white paper here: https://www.pfehealtheducate2.com/files/LTCF-White-Paper.pdf
Chronic pain is a prevalent and complex condition where evidence continues to evolve around commonly prescribed therapies. This course discusses the latest systematic review comparing tramadol with placebo in adults with chronic pain, highlighting limited analgesic benefits and the balance of potential harms versus benefits that pharmacists should understand. You will gain evidence-based insights to guide medication review, patient counseling, and clinical decision-making in chronic pain management. HOSTRachel Maynard, PharmDGameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpactGUESTEmma Murter, PharmD, MPHClinical Pharmacist, Intermountain Health Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!CPE INFORMATION Learning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Summarize the current evidence on tramadol's efficacy and safety profile in chronic pain based on placebo-controlled randomized trials.2. Describe the clinical implications of recent tramadol evidence for pharmacist-led medication management in chronic pain care.Rachel Maynard and Emma Murter have no relevant financial relationships to disclose.0.05 CEU/0.5 HrUAN: 0107-0000-26-223-H01-PInitial release date: 6/1/2026Expiration date: 6/1/2027Additional CPE details can be found here.
Chronic pain is a prevalent and complex condition where evidence continues to evolve around commonly prescribed therapies. This course discusses the latest systematic review comparing tramadol with placebo in adults with chronic pain, highlighting limited analgesic benefits and the balance of potential harms versus benefits that pharmacists should understand. You will gain evidence-based insights to guide medication review, patient counseling, and clinical decision-making in chronic pain management.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpactGUESTEmma Murter, PharmD, MPHClinical Pharmacist, Intermountain HealthGET CE FOR LISTENING!Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: All your CE in one convenient subscription.All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there's even more!The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates- Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now!PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription. CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:If you are already enrolled in this course, click here to redeem your credit. To purchase the Pharmacist CE Subscription and claim your CPE credit, click here or to purchase this course individually, click here. CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Summarize the current evidence on tramadol's efficacy and safety profile in chronic pain based on placebo-controlled randomized trials.2. Describe the clinical implications of recent tramadol evidence for pharmacist-led medication management in chronic pain care.Rachel Maynard and Emma Murter have no relevant financial relationships to disclose.0.05 CEU/0.5 HrUAN: 0107-0000-26-223-H01-PInitial release date: 6/1/2026Expiration date: 6/1/2027Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
Listen in as our expert panel unpacks updated definitions of complicated vs. uncomplicated urinary tract infections, navigates antibiotic selection and duration, and shares the latest evidence-based strategies to stop recurrent UTIs in their tracks.Special guests:Dana Bowers, PharmD, BCPS, BCIDPAssociate ProfessorWashington State UniversityAkshith Dass, PharmD, MPH, BCPS, BCIDPAssistant Professor of Pharmacy PracticeNortheast Ohio Medical UniversityPharmacy Clinical Specialist Cleveland Clinic Mercy HospitalYou'll also hear practical advice from panelists on TRC's Editorial Advisory Board:Craig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in April 2026.
Learning the “basics” of AI begins with understanding how AI can help lighten the load family medicine educators carry every day in the clinic and classroom. In the first episode of our AI Deep Dive Summer Series, Drs Linda Chang and Rika Bajra discuss how AI has already affected medical education, from curriculum design and competency-based education to formative assessment and personalized learning. They show how AI literacy allows educators to reclaim time to focus on the human-centered aspects of patient care and medical education. And if you feel like it's too late to start learning about AI, they offer practical tips for both using and teaching AI in medical education. Hosted by Omari A. Hodge, MD, FAAFP and Jay-Sheree Allen Akambase, MDCopyright © Society of Teachers of Family Medicine, 2026Resources:Artificial Intelligence and Machine Learning for Primary Care Curriculum (AiMPC) CourseEthical Use of AI in the Family Medicine Clinic - STFM WebinarAn Opportunity to Thrive - AI in Family Medicine - STFM PodcastEstablishing a National Framework for Family Medicine AI Centers of Excellence - Fam Med.Linda Chang, PharmD, MPHDr Chang is an Associate Professor of Clinical Medicine at the University of Illinois Chicago (UIC) College of Medicine Rockford, with a background as a board-certified clinical pharmacist, a degree in Public Health, and ongoing studies toward a Master's in Health Professions Education. She spent 17 years as faculty in the Family Medicine Residency Program and currently serves as the Pharmacology Theme Director at the College of Medicine, where she teaches evidence-based medicine and public health. Her work reflects an interdisciplinary approach to medical education that integrates clinical practice, public health, and emerging technologies. As co-director of the AI in Medicine theme at UIC, Dr Chang has co-led the development and implementation of a longitudinal, integrated AI in Medicine curriculum, a fourth-year elective course, and an AI in Medicine scholarly concentration program. Rika Bajra, MDDr Bajra is an Assistant Clinical Professor in Primary Care and Population Health at Stanford School of Medicine, where she practices as a family physician and teaches medical students as the Associate Director of the Clerkship in Family and Community Medicine. In her roles as Telehealth Co-Director and Telemedicine Education Curriculum Lead, she is focused on integrating technology tools into clinical practices and medical education through a primary care lens. She has previously developed telemedicine curricula with the STFM Telemedicine Task Force and received an Association of American Medical Colleges (AAMC) grant to create a longitudinal telemedicine curriculum. Currently, Dr Bajra is exploring the integration of artificial intelligence into the Family Medicine curriculum and its application in reducing faculty burden in Objective Structured Clinical Examination (OSCE) assessments. In her personal life, she lives with her husband and three boys and enjoys hiking and traveling.Link: https://www.stfm.org/stfmpodcast062026
In this episode, Tim Pierce, PharmD, MSHA, Administrative Director, Hospital Based Practice Service Lines, Indiana University Health, discusses his transition from pharmacy leadership into hospital administration, the strategic work behind anesthesia recruitment and retention, and how IU Health is building a more sustainable workforce model.
On this episode of This Week in Pharmacy, we examine three major forces shaping healthcare today: the global impact of conflict on health security, the continued evolution of personalized specialty pharmacy care, and the over-the-counter products patients rely on most. We open the show with Aman Gupta, Managing Partner, Asia-Pacific at SPAG FINN Partners, and contributor author at MedikaLife. Aman joins TWIRx to discuss his latest MedikaLife article, which argues that global conflict is quietly undermining health security by redirecting funding, attention, and infrastructure away from healthcare and toward defense priorities. As military spending rises, health systems—especially in low- and middle-income countries—face growing pressure from shrinking access, rising costs, workforce shortages, disrupted supply chains, weakened disease surveillance, and reduced emergency preparedness. Conflicts in Ukraine, Gaza, and Sudan demonstrate how attacks on healthcare systems, displacement, malnutrition, and shortages of essential medicines can rapidly turn health access into a survival issue. Aman urges policymakers to treat health as strategic security infrastructure, not as a secondary social expense. TWIRx also gives a special shout out to the Indian Pharmaceutical Association, recognizing its continued leadership and advocacy for the pharmacy profession. Next, we welcome Dr. Chris Antypas, PharmD, with Perigon Pharmacy 360, for a discussion on how specialty pharmacy is becoming increasingly personalized. As complex therapies continue to advance, pharmacists are playing a critical role in ensuring medications and treatment plans are customized to optimize patient care. We explore how technology, workflow processes, clinical expertise, and pharmacists who deeply understand specific disease states are essential to successful specialty pharmacy outcomes. To wrap up the episode, returning guest Shanley Chien Pierce, Senior Editor, Health at U.S. News & World Report, joins us to review the latest OTC medicine and health product evaluations. Top-rated products include Children's Delsym for coughs, Unisom for sleep, and Pedialyte for electrolytes, along with skincare favorites such as La Roche-Posay for retinol and Aquaphor for lip balm. For the full list covering more than 128 categories, visit the U.S. News Best OTC Medicine & Health Products rankings. Sponsored by Perigon Pharmacy 360 Listen & Subscribe Stay connected with This Week in Pharmacy and the Pharmacy Podcast Network for conversations with pharmacy leaders, healthcare innovators, policy experts, and industry voices shaping the future of care.
"There are a lot of specifics that nurses need to keep in mind as they are administering this herpes simplex modified virus to patients because accidental exposure is of concern both to the patient, to their family members, as well as to healthcare workers. I always recommend nurses wear personal protective equipment, such as a gown, safety glasses, gloves, and/or a face shield," Heidi Finnes, PharmD, RPh, BCOP, director of clinical ambulatory practice at Mayo Clinic and assistant professor of pharmacy at Mayo Clinic Alix School of Medicine in Rochester, MN, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about oncolytic viral therapy. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by May 29, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge about the use of oncolytic viruses to treat cancer. Episode Notes Complete this evaluation for free NCPD. ONS Podcast™ episodes: Pharmacology 101 series Episode 338: High-Volume Subcutaneous Injections: The Oncology Nurse's Role Episode 330: Stay Up to Date on Safe Handling of Hazardous Drugs Episode 273: Updates in Chemotherapy and Immunotherapy ONS Voice articles: Cutaneous Malignancies Have High Response to Oncolytic Virus Plus Immunotherapy Oncolytic Virus Kills Tumor Cells While Supporting T Cells What Nurses Need to Know About Talimogene Laherparepvec for Advanced Melanoma Clinical Journal of Oncology Nursing articles: Intralesional Therapy: Consensus Statements for Best Practices in Administration From the Melanoma Nursing Initiative Safe and Effective Standards of Care: Supporting the Administration of T-VEC for Patients With Advanced Melanoma in the Outpatient Oncology Setting Oncology Nursing Forum article: Administration and Handling of Talimogene Laherparepvec: An Intralesional Oncolytic Immunotherapy for Melanoma ONS book: Guide to Cancer Immunotherapy (second edition) ONS clinical practice resource: Safe Handling of Oncolytic Viruses ONS Huddle Card: Immunotherapy Association of Community Cancer Centers (ACCC) Drugs@FDA Hematology/Oncology Pharmacy Association (HOPA) Network for Collaborative Oncology Development and Advancement (NCODA) Patient Education Sheets To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "[Oncolytic viruses] can have direct lysis to the tumor cells themselves, or they can cause immunogenic activation. They release tumor-associated antigens and then proinflammatory signals, so think of T cells, natural killer cells, those sorts of things, that can convert to immunologically cold tumors. Those are tumors that are immune silenced into hot tumors which are now immune activated. By doing that, they recruit those T cells and other cells to the area to attack both the primary tumors. But that's also thought to be how they work on distant or noninjected sites as well. This immunomodulatory capacity has led to the reclassification of oncolytic viruses as a form of cancer immunotherapy. So, think of it kind of similarly to how we think of immune checkpoint inhibitors in recruiting immune cells and leaving our immune system in the on position. This is also kind of a form of immunotherapy." TS 4:35 "One of the toxicities I know that is of significant concern to patients, family members, and healthcare workers is the incidence of herpes infections. Systemic herpetic infections are extremely rare and usually more common in patients who may be immunocompromised. In patients who also have other immune-related diseases—such as vitiligo, vasculitis, pneumonitis, sometimes worsening psoriasis—because you're mounting an immune response with these types of things, sometimes you can see a worsening of those types of immune symptoms. But for the most part, these types of side effects are very well tolerated in most patients." TS 9:07 "Talimogene is generally transmitted via bodily fluids or touch. It's not airborne. Herpes simplex virus isn't an airborne type of virus. Another thing to consider is where are you going to inject this? Are you going to do this in your infusion therapy unit? Are you going to do it in a dedicated room? Who's going to escort the patient to the room? How is the virus going to arrive at the room? How will you clean the room and all of the laboratory equipment or any of the exam tables that may be in there? I think having all of that discussed and assigned mitigates the consternation that can sometimes occur—the fear that occurs with administering a virus that is thought to be fairly communicable." TS 15:44 "Helping patients understand how this works [is important] because hearing that you're receiving a virus, particularly a herpes simplex virus, can be scary to a patient. I think understanding that it's modified or essentially we're taking the parts out of it so that we can directly inject a portion that recruits immune cells to that area, because the goal is for the oncolytic virus to attack cancer cells and then destroy them by triggering an immune response in the body." TS 20:51 "Sometimes patients are very concerned about urine in the toilet, bodily fluids, kissing loved ones, holding hands, hugging, you know, am I going to infect my loved one because I'm getting this type of an oncolytic virus therapy? I like to reassure patients that they can continue to hold hands and hug their loved ones as normal. Viral DNA is usually only present on the injection site. And as I mentioned previously, we want to cover that injection site with an occlusive dressing, at least with talimogene, for up to seven days. And particularly, if those injection sites are at all oozing or weeping, active virus is usually only on that injection site itself." TS 24:14
In this episode of the Neuroveda Podcast for Complex Health, Gillian Ehrlich sits down with returning guest Dr. Dawn Ibsen, compounding pharmacist and passionate advocate for personalized medicine. Together they unpack the science, history, and growing interest around methylene blue — from its origins as a treatment for malaria to its modern use in brain health, mitochondrial support, longevity, and biohacking.They also dive into the rapidly changing world of compounding pharmacies, including concerns surrounding compounded thyroid medications, the evolving landscape of peptide access, and the balance between innovation, safety, and patient care. This conversation explores what happens when cutting-edge medicine meets regulation and why personalized treatment still matters.Topics include:• Methylene blue safety, dosing, and mechanisms• Mitochondrial health and energy production• Compounding pharmacy quality and patient advocacy• Thyroid medication changes• Peptide regulation and current challenges• The future of personalized medicineBio: Dr. Dawn Ipsen, PharmD, FAPC, FACVP, FACA is a compounding pharmacist with more than 25-years of experience serving human and veterinary patients. She is the owner of two community-based compounding pharmacies in Washington state and is recognized for her expertise in personalized medication therapy, quality compounding practices, and patient-centered care.Dr. Ipsen holds an APC Fellowship and is also a Fellow of the American College of Veterinary Pharmacists and American College of Apothecaries, reflecting her advanced training and leadership in both human and veterinary compounding. In addition, she is a clinical instructor for the University of Washington School of Pharmacy and an affiliate faculty member for Bastyr University. Her professional focus includes women's health, hormone therapy, low-dose naltrexone, dermatology compounding, and complex veterinary medication solutions for small animals, exotic pets, and large animal patients.Dr. Ipsen is deeply engaged in pharmacy advocacy, education, and legislative efforts to protect patient access to compounded medications. She currently holds an APC Board of Directors position and is the founding chair for the WA State Pharmacy Association (WSPA) - Compounding Special Interest Group. The WSPA awarded her with the Distinguished Leadership Award in 2023 and the UW School of Pharmacy Distinguished Alumni Award in 2021. Dr. Ipsen regularly collaborates with prescribers, healthcare professionals, and educators to improve the therapeutic outcomes, health, education and vitality of the communities we serve.
This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind! We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special. This is part five of our six part series! We'd like to thank PantherX Rare for sponsoring this episode! On this episode we interview: Katie DiLorenzo, PharmD SVP - PantherRx Austin Russian - PantherRx Autumn Santeler - Polar Tech Industries Ben Heiser - Lumicera Health Services Caroline Girardeau, PharmD, MBA ACHC Chris Stewart - Petauri Natalie Bedford - McKesson
Season 10, Episode 14: Optimizing Access Through OOLD In this episode of the PQI Podcast, we explore Oncology Optimized Limited Distribution (OOLD) and its growing importance within patient-centered oncology care. Guests Jonas Congelli, RPh, and Ken Komorny, PharmD, BCPS, discuss how distribution models impact oncology practices, care coordination, and the patient experience, while highlighting the critical role of medically integrated pharmacy services in supporting timely therapy initiation, education, adherence, and adverse event management. Jonas shares the vision behind OOLD and how medically integrated oncology teams help streamline care for patients receiving oral anticancer therapies. Ken provides insight into Moffitt Cancer Center's experience navigating operational, financial, and policy challenges related to specialty pharmacy access, including advocacy efforts. The conversation also highlights how oncology practices, manufacturers, and advocacy organizations can work together to preserve coordinated care models that prioritize patient safety, communication, and continuity of care. Throughout the episode, the discussion reinforces the value of multidisciplinary collaboration and innovation in shaping the future of oncology pharmacy practice and improving outcomes for patients nationwide. Learn more about NCODA and NCODA's OOLD initiatives here.View the poster Ken discussed here.
Lisa Miller, PharmD, MSCP, joins Over the Counter to discuss fragmentation in menopause care and how pharmacists are increasingly making themselves known in the women's health space.
Join host Dr. Britney Woods, PharmD, Senior Manager on the McKesson Health Mart team, for a special Know Before You Go episode created to help independent pharmacy owners get real value from McKesson ideaShare 2026 - before they even arrive. Featuring Jaime Montuoro, PharmD, Director of Education and Practice Advancement with McKesson/Health Mart, Alanna Douglas, Senior Marketing Manager on the McKesson/Health Mart team, this conversation goes behind the scenes of how ideaShare is intentionally designed for today's independent pharmacies. Tune in to hear what education themes matter most this year, how to build a schedule that balances inspiration with practical implementation, and the inspiration behind the Health Mart Pharmacy of the Year award. Whether it's your first ideaShare or your tenth, this episode will help you show up with a plan and leave ready to put ideas into action back at your pharmacy. HostBritney Woods, PharmDSr. Manager, Community PharmacyMcKesson / Health MartGuestsJaime Montuoro, PharmDDirector of Education & Practice Advancement McKesson/Health MartAlanna DouglasSr. Marketing Manager McKessonResourcesTune into Episode 23: Community Roots to Clinical Impact – Inside a Pharmacy of the Year Winner featuring Dave Randolph and Mikayla Smith, last year's Health Mart Pharmacy of the Year winners. In this episode, they discuss how they expanded clinical services, fostered staff development, and implemented sustainable solutions for patient care while serving their rural community. Health Mart Pharmacies can access Health Mart University (HMU) to: Enroll in the Independent Insights Podcast Package to conveniently access new monthly podcast episodes and claim continuing education (CE) credit (pharmacists) for weekly GameChangers clinical episodes. Access hundreds of no-cost continuing education courses to help elevate pharmacy staff knowledge and maintain state licensure requirements ReferencesGo to mckessonideashare.com to learn more and registered attendees can login to the Attendee Hub to start planning your McKesson ideaShare 2026 now. The views and opinions expressed in this podcast are those of the guest and do not necessarily represent the views or positions of Health Mart, McKesson or its affiliates or subsidiaries ("McKesson”). The information provided herein is for informational purposes only and does not constitute the rendering of clinical, legal or other professional advice by McKesson.
It's YOUR time to #EdUp with Dr. Kathy Bakhit, Community College Faculty Fellow, University of La VerneIn this episode, sponsored by EdUp Leadership, the HigherEd PodCon II happening July 16 & 17, & the 2026 AcOps Conference July 29-31 by CoursedogYOUR host is Dr. Jodi Blinco How does a redesigned doctoral program with research built into coursework ensure students graduate with dissertations in hand instead of becoming ABDs?Why does an immigrant woman who started in ESL classes & put 3 kids through medical school & PharmD believe education still pays off despite the narrative?What makes community building the back to the future solution when AI causes mistrust & we don't know what's real anymore?Listen in to #EdUpThank YOU so much for tuning in. Join us on the next episode for YOUR time to EdUp!Connect with YOUR EdUp Team - Elvin Freytes & Dr. Joe Sallustio● Join YOUR EdUp community at The EdUp ExperienceWe make education YOUR business!P.S. Want access to the only intelligence platform built exclusively from presidential conversations in higher ed? Well, we have an app for that!Join EdUp Leadership!
The Perfect Stool Understanding and Healing the Gut Microbiome
Amy Behimer, PharmD shares her journey from multiple autoimmune diagnoses including MS, to building sustainable habits that transformed her health. We discuss gut health, constipation, dopamine-driven cravings, mindset shifts and why small lifestyle changes are often the key to long-term healing. Lindsey Parsons, your host, helps clients solve gut issues and reverse autoimmune disease naturally. Take her quiz to see which stool or functional medicine test will help you find out what's wrong. She's a Certified Health Coach at High Desert Health in Tucson, Arizona. She coaches clients locally and nationwide. You can also follow Lindsey on Facebook, Tiktok, Instagram, Pinterest, Mastodon or X, or reach her via email at lindsey@highdeserthealthcoaching.com to set up your free 30-minute Gut Healing Breakthrough Session. Show Notes
Discover the essential contributions of pharmacists in patient care with We're Your Pharmacist, a monthly podcast from ASHP. This episode features Anastasiya Shor, director of the drug information center and assistant professor at Touro College of Pharmacy. She shares what inspired her to pursue a career in pharmacy and offers insight into the vital role pharmacists play in supporting patients. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Melatonin—widely available over the counter and often perceived as“natural and safe”—has become increasingly used by caregivers toaddress sleep disturbances in children and adolescents, yet its properrole and safety profile in pediatrics remain nuanced and evolving. Thiscourse examines current evidence on indications such as insomnia andcircadian rhythm sleep disorders, highlights concerns aboutunregulated supplement use and adverse effects, and reviews practicalconsiderations for safe and informed use in pediatric patients. You willgain insight into how to support caregivers with balanced counseling,emphasize behavioral and environmental strategies, and apply clinicaljudgment when melatonin is being considered for sleep managementin pediatric patients.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpactGUESTMonica Bogenschutz, PharmD, BCPS, BCPPS, DPLA, FPPAPediatric Clinical Pharmacist and PGY2 Pediatric Pharmacy Residency Program Director at UW Health Pharmacists, REDEEM YOUR CPE HERE!CPE is available to Health Mart franchise members onlyTo learn more about Health Mart, click here: https://join.healthmart.com/PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by enrolling in the course. Click here to enroll!CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe common pediatric indications and available evidence for melatonin use in children and adolescents2. Identify pharmacist considerations related to safety, dosing, behavioral counseling, and monitoring when melatonin is recommended or used in pediatric patients.Rachel Maynard and Monica Bogenschutz have no relevant financial relationships to disclose.0.075 CEU/0.75 HrUAN: 0107-0000-26-222-H01-P Initial release date: 5/25/2026Expiration date: 5/25/2027Additional CPE details can be found here.
Melatonin—widely available over the counter and often perceived as “natural and safe”—has become increasingly used by caregivers to address sleep disturbances in children and adolescents, yet its proper role and safety profile in pediatrics remain nuanced and evolving. This course examines current evidence on indications such as insomnia and circadian rhythm sleep disorders, highlights concerns about unregulated supplement use and adverse effects, and reviews practical considerations for safe and informed use in pediatric patients. You will gain insight into how to support caregivers with balanced counseling, emphasize behavioral and environmental strategies, and apply clinical judgment when melatonin is being considered for sleep management in pediatric patients.HOSTRachel Maynard, PharmD GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpactGUESTMonica Bogenschutz, PharmD, BCPS, BCPPS, DPLA, FPPAPediatric Clinical Pharmacist and PGY2 Pediatric Pharmacy Residency Program Director at UW HealthGET CE FOR LISTENING!Stay Compliant. Grow Clinically. Practice with Confidence. Pharmacist CE Subscription: All your CE in one convenient subscription.All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there's even more!The Pharmacist CE Subscription includes: - Compliance and licensure CE - GameChangers Clinical Updates- Practical continuing education across patient care topics *The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training. Purchase Now!PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription. CPE REDEMPTIONThis course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:If you are already enrolled in this course, click here to redeem your credit. To purchase the Pharmacist CE Subscription and claim your CPE credit, click here or to purchase this course individually, click here.CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe common pediatric indications and available evidence for melatonin use in children and adolescents2. Identify pharmacist considerations related to safety, dosing, behavioral counseling, and monitoring when melatonin is recommended or used in pediatric patients.Rachel Maynard and Monica Bogenschutz have no relevant financial relationships to disclose.0.075 CEU/0.75 HrUAN: 0107-0000-26-222-H01-P Initial release date: 5/25/2026Expiration date: 5/25/2027Additional CPE details can be found here.Follow CEimpact on Social Media:LinkedInInstagram
On this episode of This Week in Pharmacy, we examine two major forces reshaping the profession: the unfinished business of pharmacist provider status and the legal landscape around direct-to-consumer pharmaceutical distribution. In part one, Erik Abel, PharmD, MBA, discusses his May 2026 analysis, “So Pharmacists Want to Be a Provider: Where the Profession Lost Its Way and Perhaps a Path to Get Back.” Abel argues that pharmacy's provider-status challenge is not a lack of clinical evidence, but a lack of operational infrastructure: credentialing, payer contracting, revenue cycle management, interoperability, and scalable business models. In part two, Darshan Kulkarni, PharmD, Esq., joins the show to discuss direct-to-consumer pharmaceutical distribution, legal risk, regulatory scrutiny, telehealth-linked prescribing, manufacturer strategy, and what pharmacists need to understand as drug distribution moves closer to the patient. This week in pharmacy news, Pittsburgh-area pharmacies continue to face uneven access to Adderall and other ADHD medications, years after the FDA first identified shortages in 2022. Patients are still calling multiple pharmacies, switching medications, rationing doses, or going without treatment as availability varies by dosage, formulation, manufacturer, and wholesaler. Pharmacists are also using medication therapy management to protect older adults from preventable medication-related harm. MTM reviews can identify risky prescriptions and OTC products, including diphenhydramine, duplicate therapies, drug interactions, and long-term proton pump inhibitor use that may need reassessment. In 340B news, CVS Health is facing federal lawsuits from major health systems alleging CVS Specialty and WellPartner improperly retained approximately $250 million in savings that should have gone back to covered entities. The litigation adds pressure to debates over PBM integration, contract pharmacy arrangements, and 340B transparency. On Capitol Hill, lawmakers are pressing the Department of Defense to commit to annual audits of the TRICARE pharmacy contract as concerns continue around PBM conflicts of interest, reimbursement practices, network adequacy, and access for independent and community pharmacies.
Send us Fan MailSchedule an Rx Assessment: https://www.sykes-cpa.com/rx-assessment-service/Support Didi's Campaign: https://www.didiforcongress.com/ What does it take for a pharmacist to go from opening a compounding pharmacy to running for U.S. Congress? Turns out, it takes a lot. In this episode, Austin and Scotty sit down with Dr. Ndidiamaka Okpareke, PharmD, Owner of Olive Tree Compounding, and U.S. Congressional Candidate for NM CD1 to find out. We talk about: - Didi's path to pharmacy ownership - Top advocacy issues facing compounding pharmacies - Over-regulation of 503A compounding pharmacies and the peptide debate - Campaign updates And more! Stay connected with Dr. Ndidiamaka Okpareke: Didi's website: https://www.didiforcongress.com/ Didi's Instagram: https://www.instagram.com/didiforcongress/ Didi's Facebook: https://www.facebook.com/DidiForCongress/ Didi's Twitter (X): https://x.com/DidiForCongress Olive Tree Compounding: https://www.olivetreecompounding.com/ Check out all our social media:Facebook: https://www.facebook.com/sykesandcoTwitter: https://twitter.com/OllinSykesLinkedIn: https://www.linkedin.com/company/sykes-&-company-p-a-?trk=tyahScotty Sykes – CPA, CFP LinkedIn: https://www.linkedin.com/in/scottysykes/Scotty Sykes – CPA, CFP Twitter: https://twitter.com/ScottySykesCPAMore resources on this topic: Podcast – Inside the Fight for Compounding with Scott Brunner: https://www.youtube.com/watch?v=o5X4cfI9gY4&list=PLbdUM3PBAwLvuE95Acu1EbvpV_PUBqVfo&index=17 Podcast – And Out Came the PBM Reform: https://www.youtube.com/watch?v=f-dK5NBK4K8&list=PLbdUM3PBAwLvuE95Acu1EbvpV_PUBqVfo&index=7
Redefining Healthcare Through Relationships, Purpose, and Personalized Care with Dr. Stevi Jenkins-KellyGuest: Dr. Stevi Jenkins-Kelly, PharmD, Founder of My Concierge Pharmacy Host: Julie RigaWhat if your pharmacist knew your name, your goals, and your complete health story rather than just your prescription number? In this episode, Julie Riga sits down with Dr. Stevi Jenkins-Kelly, a visionary pharmacist and founder of My Concierge Pharmacy. Together they explore how she left corporate pharmacy to build something new, a practice grounded in personalized service, trust, and a whole-patient approach to wellness. If you have ever felt like just a number in the system, this episode will inspire you to lead with more intention in your own work and life.Redefining Healthcare Through Relationships, Purpose, and Personalized CareAbout the GuestDr. Stevi Jenkins-Kelly is a licensed pharmacist with over 25 years of experience, including time at major chains such as CVS and Publix. She founded My Concierge Pharmacy in West Palm Beach, Florida after finding that most systems are built for volume, not genuine patient care. Her practice is completely independent, self-trademarked, and rooted in one guiding principle: pharmacy as a relationship, not a transaction.She holds advanced certifications in diabetes care and collaborative practice and specializes in medication management, chronic disease support, and preventative health. She serves patients across Florida and Pennsylvania, with direct delivery and personalized consultations at every stage of life.Fun Fact: Dr. Stevi loves salmon in every form. Lox and bagels with capers and onions is her absolute go-to.The Three Ingredients for Concierge Success1. Service as a Foundation True service is never transactional. Dr. Stevi built her team culture around being service-minded at every level. When you are moving a patient out of a system that has failed them, you must become the new definition of what great care looks like.2. Trust Through Follow-Through Trust is built by doing what you say you will do, every single time. My Concierge Pharmacy proactively manages patient profiles, coordinates with providers, and connects with each patient a minimum of six times per year. Patients soon find they do not need to chase anyone because someone is consistently and genuinely watching over their care.3. Customization That Feels Personal Concierge care is never cookie-cutter. Whether the patient is a parent preparing for summer, an elderly person managing chronic illness, or a performance athlete focused on longevity, every care plan is built specifically around that individual. Intentional personalization is what sets real concierge care apart from everything else.Key Insights from This EpisodePharmacists are trained in anatomy, biochemistry, and treatment protocol, making them the chemistry and treatment counterpart to a physician's diagnostic approach. Most patients never access this full depth of knowledge because corporate environments do not allow for it. Concierge pharmacy is changing that reality.Dr. Stevi also applies a micro-therapy model, focusing on one health challenge at a time rather than overwhelming patients with everything at once. This approach builds clarity, confidence, and a genuine sense of control over personal health, growth, and life balance.Connect with Dr. Stevi Jenkins-KellyWebsite: www.myconciergepharmacy.com Book a consult to explore whether concierge pharmacy is right for you. Service covers Florida and Pennsylvania with direct home delivery available.Connect with Julie RigaExplore leadership coaching, transformation, and purposeful living at the link below.Subscribe to Stay On Course wherever you listen to podcasts and share this episode with someone who deserves better from their healthcare journey.#StayOnCourse #PurposeDriven #LeadershipMindset #AuthenticGrowth #TransformYo
This week, This Week in Pharmacy examines several stories shaping the business, clinical, and legal future of pharmacy practice. In TWIRx News from Pharmacy Times from Megan Maroney, PharmD, BCPP, FAAPP, focused on antidepressant use, withdrawal concerns, deprescribing, and shared decision-making. The key takeaway: patients should never stop antidepressants abruptly. Pharmacists can play a vital role in reducing stigma, educating patients, and supporting safe conversations about tapering, side effects, and long-term treatment. In health technology news, FDB research presented at the 2026 AMIA Amplify Informatics Conference found that patient-specific, risk-based medication guidance reduced pharmacy alert volume by 70% in a high-volume community pharmacy setting. The model consolidates alerts into one actionable message tied to the patient's most relevant risk, helping reduce alert fatigue and improve workflow. Finally, we review a federal court ruling in Eli Lilly's lawsuit against Houston-based Empower Pharmacy over compounded tirzepatide versions of Mounjaro and Zepbound. The judge dismissed key federal trademark and Texas unfair competition claims, while allowing other state claims to continue. Andy Crawford, with Keysource is back on TWIRx talking about the U.S. Supreme Court taking up Hikma Pharmaceuticals USA Inc. v. Amarin Pharma Inc., a case that could significantly affect generic drug competition. At issue is whether Hikma's marketing materials and public communications around its generic version of Amarin's fish oil-based cardiovascular drug improperly promoted a still-patented use. Hikma and the broader generic industry argue the case is about protecting “skinny label” rules, which allow generics to carve out patented indications while still bringing lower-cost medications to market. For pharmacists, the decision could influence generic availability, substitution confidence, pricing pressure, and how manufacturers communicate with providers and pharmacies. Thanks to our sponsors, CassianRx and IPC, for supporting independent pharmacy, innovation, and the future of patient-centered care.
This is the Pharmacy Podcast Network's ASEMBIA 2026 rewind! We're dedicated to bringing you inside coverage of the pharmacy nation's biggest events with on the street style interviews with keynote speakers, attendees, exhibitors, and recurring guests who make each year special. This is part one of our six part series! We'd like to thank Clearway Health for sponsoring this episode! On this episode we interview: Allison Arant - Clearway Health Jennifer Noonan - Accessia Health Aleata Postell - CenterWell Derek Dennis, PharmD - Clearway Health Dr. Shafaat Pirani, PharmD, BCGP - Wellgistics Health Meghna Misra - Claritas Rx
© 2020-2026 Ivy Podcast Discovery LLC
